
Cartesian Therapeutics Inc (RNAC)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy RNAC Stock
Start investing in RNAC
About Cartesian Therapeutics Inc (RNAC)
Market cap | $316.12M |
Yesterday's volume | 159 |
Revenue (TTM) | $47.94M |
Avg. daily volume | 71.94K |
EBITDA (TTM) | -$51.78M |
Open | $11.95 |
Price / earnings ratio | -0.23x |
Yesterday's range | $11.95 - $12.61 |
Debt / equity | — |
52 week range | $8.46 - $26.5 |
5 year debt / equity | -41.17x |
Beta (LTM) | 2.13x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 12.34x |
Ex-dividend date | — |
Next earnings | Aug 7, 2025 |
Dividend payable date | — |
RNAC Stock Rating
RNAC Stock News
View all



Frequently Asked Questions (FAQ)
How to buy RNAC stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in RNAC stock
Navigate to the Explore page. Then, type RNAC into the search bar. When you see RNAC stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased RNAC stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Cartesian Therapeutics Inc Stock Earnings
The value each RNAC share was expected to gain vs. the value that each RNAC share actually gained.
RNAC (RNAC) reported Q1 2025 earnings per share (EPS) of -$0.68, missing estimates of -$0.61 by 11.48%. In the same quarter last year, RNAC's earnings per share (EPS) was -$10.50. RNAC is expected to release next earnings on 08/07/2025, with an earnings per share (EPS) estimate of -$0.76.